ReviewPsychiatry and clinical neurosciences2016

Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.

Emily L Ricq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.